No clinical study data is present in the provided text, which consists only of the journal's editorial board information.
This consensus document provides best practice guidelines for balancing ischemic and bleeding risks in AF patients requiring antithrombotic therapy for ACS or PCI.
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.
Huber et al. (2009) studied Atrial Fibrillation and Acute Coronary Syndrome. No clinical study data is present in the provided text, which consists only of the journal's editorial board information.